The drug maker claims clinical trials of its new antiviral pill molnupiravir shows the drug halved the risk of hospitalization or death when given to high-risk people shortly after infection with COVID-19.
from WebMD Health https://www.webmd.com/vaccines/covid-19-vaccine/news/20211001/merck-to-ask-fda-for-emergency-approval-of-its-new-antiviral-pill-for-covid?src=RSS_PUBLIC
0 Comments:
Post a Comment